UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): May 17, 2017

 

INGREDION INCORPORATED

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

 

1-13397

 

22-3514823

(State or Other Jurisdiction

 

(Commission

 

(IRS Employer

of Incorporation)

 

File Number)

 

Identification No.)

 

5 Westbrook Corporate Center, Westchester, Illinois

 

60154-5749

(Address of Principal Executive Offices)

 

(Zip Code)

 

(708) 551-2600

(Registrant’s Telephone Number, Including Area Code)

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

o            Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

 

 



 

Item 5.07              Submission of Matters to a Vote of Security Holders.

 

(a)                                 The annual meeting of the stockholders of Ingredion Incorporated (the “Company”) was held on May 17, 2017.  As of the record date of the meeting, 71,680,758 shares of common stock were issued and outstanding.  At the meeting, holders of 63,075,713 shares (87.99% of the issued and outstanding shares) were present in person or represented by proxy, constituting a quorum.

 

(b)                                 At the annual meeting, the Company’s stockholders (i) elected all of the Company’s nominees for election as director, (ii) approved the compensation of the Company’s named executive officers, (iii) recommended that the advisory stockholder vote to approve the compensation of the Company’s named executive officers occur every year and (iv) ratified the appointment by the Audit Committee of the Company’s Board of Directors of the firm of KPMG LLP as the independent registered public accounting firm of the Company and its subsidiaries, in respect of the Company’s operations in 2017.  Under the Company’s by-laws, in uncontested elections, directors are elected by a majority of the votes cast. In contested elections where the number of nominees exceeds the number of directors to be elected, directors are elected by a plurality vote.  The vote of a majority of the shares present at the meeting in person or by proxy and entitled to vote is required to approve the compensation of the Company’s named executive officers and to approve the ratification of the appointment of the Company’s independent registered public accounting firm. For the vote on whether to hold a stockholder vote to approve the compensation of the Company’s named executive officers every one year, two years or three years, the alternative receiving the most votes cast is considered the stockholder recommendation with respect to the frequency of such votes. The number of votes cast for, against or withheld and the number of abstentions and broker non-votes as to each matter submitted to a vote of security holders were as follows:

 

1.                                      Election of Directors

 

The following nominees were elected to serve as directors of the Company, each for a term of one year and until his or her successor has been elected and qualified or until his or her earlier death, resignation or removal, with votes as follows:

 

Name

 

Votes For

 

Votes Against

 

Abstentions

 

Broker Non-Votes

Luis Aranguren-Trellez

 

56,429,631

 

922,229

 

40,602

 

5,683,251

David B. Fischer

 

56,824,204

 

522,668

 

45,590

 

5,683,251

Ilene S. Gordon

 

53,757,132

 

2,873,634

 

761,696

 

5,683,251

Paul Hanrahan

 

56,554,435

 

796,441

 

41,586

 

5,683,251

Rhonda L. Jordan

 

56,755,668

 

594,364

 

42,430

 

5,683,251

Gregory B. Kenny

 

55,946,406

 

1,403,230

 

42,826

 

5,683,251

Barbara A. Klein

 

55,871,302

 

1,482,690

 

38,470

 

5,683,251

Victoria J. Reich

 

56,987,114

 

366,941

 

38,407

 

5,683,251

Jorge A. Uribe

 

57,063,441

 

288,965

 

40,056

 

5,683,251

Dwayne A. Wilson

 

56,953,552

 

397,598

 

41,312

 

5,683,251

 

2



 

2.                                      Advisory Vote on Compensation of Named Executive Officers

 

The votes on a proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, the accompanying compensation tables and the related narrative disclosures in the proxy statement for the Company’s 2017 annual meeting of stockholders were as follows:

 

Votes For

 

Votes Against

 

Abstentions

 

Broker Non-Votes

53,469,436

 

3,240,429

 

682,597

 

5,683,251

 

3.                                      Advisory Vote on the Frequency of the Advisory Vote on Compensation of Named Executive Officers

 

The votes on a proposal asking stockholders to vote on an advisory basis for the Company to request future stockholder advisory votes on the compensation of the Company’s named executive officers every year, every two years or every three years were as follows:

 

One Year

 

Two Years

 

Three Years

 

Abstentions

 

Broker Non-Votes

48,523,276

 

87,215

 

8,711,286

 

70,685

 

5,683,251

 

4.                                      Ratification of Appointment of Independent Registered Public Accounting Firm

 

The votes on a proposal to ratify the appointment by the Audit Committee of the Company’s Board of Directors of the firm of KPMG LLP as the independent registered public accounting firm of the Company and its subsidiaries, in respect of the Company’s operations in 2017, were as follows:

 

Votes For

 

Votes Against

 

Abstentions

 

Broker Non-Votes

62,006,894

 

1,019,997

 

48,822

 

 

There were no other matters submitted to a vote of security holders at the Company’s annual meeting.

 

(c)                                  Not applicable.

 

(d)                                 A majority of the votes cast by stockholders were voted, on an advisory basis, to hold an advisory vote to approve compensation of executives as required by section 14A(a)(2) of the Securities Exchange Act of 1934, as amended, every year.  In line with this recommendation by our stockholders, the Board of Directors has decided that it will include an advisory stockholder vote on the compensation of executives in the Company’s proxy materials every year until the next required vote on the frequency of stockholder votes on the compensation of executives.

 

Item 8.01                                           Other Events.

 

On May 17, 2017, the independent directors of the Company appointed Gregory B. Kenny, an independent director of the Company, to the position of Lead Director of the Board of Directors of the Company, to serve as Lead Director for a term of one year and until his successor has been elected and qualified or until his earlier death, resignation, retirement, removal or disqualification.

 

3



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

INGREDION INCORPORATED

 

 

 

 

Date: May 22, 2017

By:

/s/ Christine M. Castellano

 

 

Christine M. Castellano

 

 

Senior Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer

 

4